You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 23, 2024

Claims for Patent: 10,730,873


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 10,730,873
Title:Salts and crystalline forms of an apoptosis-inducing agent
Abstract: Salts and crystalline forms of 4-(4-{[2-(4-chlorophenyl)-4,4-dimethylcyclohex-1-en-1-yl]methyl}piperazin- -1-yl)-N-({3-nitro-4-[(tetrahydro-2H-pyran-4-ylmethyl)amino]phenyl}-sulfon- yl)-2-(1H-pyrrolo[2,3-b]pyridin-5-yloxy)benzamide are suitable active pharmaceutical ingredients for pharmaceutical compositions useful in treatment of a disease characterized by overexpression of one or more anti-apoptotic Bcl-2 family proteins, for example cancer.
Inventor(s): Catron; Nathaniel (Vernon Hills, IL), Chen; Shuang (Gurnee, IL), Gong; Yuchuan (Waukegan, IL), Zhang; Geoff G. (Vernon Hills, IL)
Assignee: AbbVie Inc. (Chicago, IL)
Application Number:15/806,964
Patent Claims: 1. A compound 4-(4-{[2-(4-chlorophenyl)-4,4-dimethylcyclohex-1-en-1-yl]methyl}piperazin- -1-yl)-N-({3-nitro-4-[(tetrahydro-2H-pyran-4-ylmethyl)amino]phenyl}sulfony- l)-2-(1H-pyrrolo[2,3-b]pyridin-5-yloxy)benzamide (Compound 1) in a crystalline form, wherein the crystalline form is Compound 1free base hydrate, characterized by a powder X-ray diffraction pattern having five or more peaks selected from those at 3.3, 6.4, 7.1, 7.3, 10.1, 11.4, 13.2, 14.4, 14.6, 15.1, 15.8, 16.2, 17.2, 17.6, 18.0, 18.6, 19.0, 19.5, 19.8, 20.2, 20.7, 21.0, 22.5, 23.0, 26.0, 28.9, and 29.2 degrees 2.theta.(pattern D), each peak being .+-.0.2 degrees 2.theta., when measured at about 25.degree. C. with Cu K.sub..alpha.radiation at 1.54178 .ANG..

2. A pharmaceutical composition comprising the compound of claim 1 and one or more pharmaceutically acceptable excipients.

3. A process for preparing a pharmaceutical solution of Compound 1 comprising dissolving the compound of claim 1 in a pharmaceutically acceptable solvent or mixture of solvents.

4. A compound 4-(4-{[2-(4-chlorophenyl)-4,4-dimethylcyclohex-1-en-1-yl]methyl}piperazin- -1-yl)-N-({3-nitro-4-[(tetrahydro-2H-pyran-4-ylmethyl)amino]phenyl sulfonyl)-2-(1H-pyrrolo[2,3-b]pyridin-5-yloxy)benzamide (Compound 1) in a crystalline form, characterized by a powder X-ray diffraction pattern having peaks at 7.1, 14.4, and 19.0 degrees 2.theta., each peak being .+-.0.2 degrees 2.theta., when measured at about 25.degree. C. with Cu K.sub..alpha.radiation at 1.54178 .ANG..

5. A pharmaceutical composition comprising the compound of claim 4 and one or more pharmaceutically acceptable excipients.

6. A process for preparing a pharmaceutical solution of Compound 1comprising dissolving the compound of claim 4 in a pharmaceutically acceptable solvent or mixture of solvents.

7. A compound 4-(4-{[2-(4-chlorophenyl)-4,4-dimethylcyclohex-1-en-1-yl]methyl}piperazin- -1-yl)-N-({3-nitro-4-[(tetrahydro-2H-pyran-4-ylmethyl) amino]phenylsulfonyl)-2-(1H-pyrrolo[2,3-b]pyridin-5-yloxy)benzamide (Compound 1) in a crystalline form, characterized by a powder X-ray diffraction pattern having peaks at 19.8, 20.7, and 22.5 degrees 2.theta., each peak being .+-.0.2 degrees 2.theta., when measured at about 25.degree. C. with Cu K.sub..alpha.radiation at 1.54178 .ANG..

8. A pharmaceutical composition comprising the compound of claim 7 and one or more pharmaceutically acceptable excipients.

9. A process for preparing a pharmaceutical solution of Compound 1comprising dissolving the compound of claim 7 in a pharmaceutically acceptable solvent or mixture of solvents.

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.